Stem Cell Therapy Among Hot Topics at AAO 2017

Source: Medscape

A potential treatment for two eye conditions that currently have none — inherited retinal disease and dry age-related macular degeneration — will be among the most anticipated research presented at the American Academy of Ophthalmology (AAO) 2017 Annual Meeting, according to a report in Medscape.

Investigators will report the latest findings on the use of human embryonic stem cell–derived retinal pigment epithelial cells, which could restore vision to persons with Stargardt’s macular dystrophy and non-neovascular (dry) macular degeneration. The US Food and Drug Administration is expected to approve this treatment within the next 2 months, so these papers are very timely.

Read the full article.

Related Content